Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.12 trillion and total revenue of $111.26 billion.
Market Cap
1.12T
Revenue
111.26B
Profits
-40.29B
PE Ratio
n/a
Profit Margin
-36.22%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 107.83B | -0.81% | 796,918 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 71.36B | -0.80% | 729,172 | 14.92B |
| 3 | ARGX | argenx SE | 48.73B | 0.23% | 188,244 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.51B | -4.32% | 1,115,443 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 32.66B | -0.48% | 116,039 | 5.34B |
| 6 | RVMD | Revolution Medicines, Inc. | 29.34B | -3.22% | 2,584,284 | - |
| 7 | RPRX | Royalty Pharma plc | 29.33B | -1.24% | 2,350,264 | 2.38B |
| 8 | INSM | Insmed Incorporated | 28.76B | -2.25% | 1,562,257 | 606.42M |
| 9 | BNTX | BioNTech SE | 24.67B | -5.71% | 1,082,648 | 3.37B |
| 10 | ROIV | Roivant Sciences Ltd. | 19.92B | -2.45% | 4,232,255 | 13.31M |
| 11 | INCY | Incyte Corporation | 19.36B | 1.72% | 1,203,655 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 17.99B | -1.24% | 10,233,113 | 2.23B |
| 13 | GMAB | Genmab A/S | 16.37B | -0.26% | 722,242 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 13.65B | -3.68% | 458,841 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.29B | -3.59% | 1,805,306 | 502.08M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.51B | -24.91% | 18,118,165 | - |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 12.48B | -0.15% | 570,999 | 4.27B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.44B | 0.68% | 1,665,936 | 1.06B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.78B | -0.71% | 196,655 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.10B | -1.75% | 3,955,265 | 2.32B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 10.56B | -0.59% | 1,635,562 | 638.50M |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.48B | 1.81% | 1,554,315 | 1.09B |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.45B | 0.28% | 1,335,417 | 3.22B |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 9.03B | 1.68% | 351,281 | 7.46M |
| 25 | ABVX | ABIVAX Société Anonyme | 8.96B | 0.20% | 443,081 | 5.37M |
| 26 | TECH | Bio-Techne Corporation | 8.61B | -0.54% | 1,954,344 | 1.22B |
| 27 | PCVX | Vaxcyte, Inc. | 8.22B | -0.54% | 697,208 | - |
| 28 | CYTK | Cytokinetics, Incorporated | 7.87B | -0.97% | 2,457,552 | 88.04M |
| 29 | KRYS | Krystal Biotech, Inc. | 7.83B | 1.44% | 255,802 | 389.13M |
| 30 | NUVL | Nuvalent, Inc. | 7.79B | -1.24% | 331,372 | - |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.58B | 0.47% | 978,012 | 1.40B |
| 32 | IBRX | ImmunityBio, Inc. | 7.34B | 0.14% | 7,080,892 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.59B | -0.44% | 693,608 | 51.48M |
| 34 | PTGX | Protagonist Therapeutics, Inc. | 6.28B | -0.61% | 447,658 | 46.02M |
| 35 | COGT | Cogent Biosciences, Inc. | 6.26B | 2.35% | 1,951,213 | - |
| 36 | CNTA | Centessa Pharmaceuticals plc | 6.12B | 0.38% | 868,548 | 15.00M |
| 37 | TERN | Terns Pharmaceuticals, Inc. | 6.11B | - | 2,751,160 | - |
| 38 | BLTE | Belite Bio, Inc | 6.09B | -2.71% | 77,942 | - |
| 39 | CELC | Celcuity Inc. | 6.07B | 3.54% | 2,077,323 | - |
| 40 | SYRE | Spyre Therapeutics, Inc. | 5.99B | -6.76% | 1,463,597 | - |
| 41 | APGE | Apogee Therapeutics, Inc. | 5.96B | -2.58% | 472,250 | - |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 5.89B | -0.80% | 497,092 | 521.31M |
| 43 | CGON | CG Oncology, Inc. | 5.60B | -0.70% | 794,961 | 4.04M |
| 44 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.59B | 0.55% | 611,029 | 189.76M |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.53B | -0.53% | 1,586,839 | - |
| 46 | CORT | Corcept Therapeutics Incorporated | 5.52B | 10.53% | 3,274,563 | 769.10M |
| 47 | IMVT | Immunovant, Inc. | 5.52B | -0.09% | 929,793 | - |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 5.42B | 0.16% | 1,805,421 | 7.50M |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.40B | 0.14% | 1,323,251 | 1.73B |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | 0.02% | 1,711,387 | 1.00B |
| 51 | CAI | Caris Life Sciences, Inc. | 5.22B | -2.79% | 2,086,543 | 812.03M |
| 52 | TGTX | TG Therapeutics, Inc. | 5.00B | 0.21% | 1,503,078 | 616.29M |
| 53 | CRSP | CRISPR Therapeutics AG | 4.97B | -1.36% | 906,770 | 3.51M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.76B | -0.43% | 484,610 | 2.04M |
| 55 | LGND | Ligand Pharmaceuticals Incorporated | 4.56B | -0.88% | 232,535 | 268.09M |
| 56 | LEGN | Legend Biotech Corporation | 4.36B | 0.30% | 1,116,735 | 1.03B |
| 57 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.09B | 0.62% | 1,062,691 | 7.70M |
| 58 | TVTX | Travere Therapeutics, Inc. | 4.08B | 4.75% | 2,188,500 | 490.73M |
| 59 | TLX | Telix Pharmaceuticals Limited | 3.81B | 2.36% | 136,809 | 803.79M |
| 60 | MANE | Veradermics, Incorporated | 3.77B | 2.02% | 995,878 | - |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.76B | -2.23% | 1,449,316 | 1.07B |
| 62 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.51B | 2.17% | 1,417,727 | 588.99M |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.48B | -3.78% | 2,879,868 | - |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.29B | -1.13% | 609,606 | - |
| 65 | NAMS | NewAmsterdam Pharma Company N.V. | 3.27B | -0.46% | 1,455,988 | 22.50M |
| 66 | KLRA | Kailera Therapeutics, Inc. | 3.26B | 0.60% | 551,199 | - |
| 67 | RCUS | Arcus Biosciences, Inc. | 3.23B | 0.71% | 986,410 | 247.00M |
| 68 | ALMS | Alumis Inc. | 3.20B | 1.98% | 798,714 | 24.05M |
| 69 | ORKA | Oruka Therapeutics, Inc. | 3.14B | -8.52% | 3,952,545 | - |
| 70 | ERAS | Erasca, Inc. | 3.12B | -5.82% | 9,788,768 | - |
| 71 | BEAM | Beam Therapeutics Inc. | 3.08B | 1.22% | 1,461,346 | 139.74M |
| 72 | TNGX | Tango Therapeutics, Inc. | 3.03B | -2.96% | 3,017,333 | 62.38M |
| 73 | GPCR | Structure Therapeutics Inc. | 3.00B | 1.83% | 1,351,823 | - |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 2.92B | 0.56% | 810,747 | 376.07M |
| 75 | NKTR | Nektar Therapeutics | 2.92B | 1.67% | 689,762 | 55.23M |
| 76 | DNLI | Denali Therapeutics Inc. | 2.90B | -2.24% | 1,514,442 | - |
| 77 | DYN | Dyne Therapeutics, Inc. | 2.87B | -0.91% | 1,176,626 | - |
| 78 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.09% | 1,342,944 | 190.41M |
| 79 | KOD | Kodiak Sciences Inc. | 2.73B | 1.10% | 526,660 | - |
| 80 | TARS | Tarsus Pharmaceuticals, Inc. | 2.71B | 0.02% | 576,704 | 451.36M |
| 81 | IMNM | Immunome, Inc. | 2.57B | -0.92% | 986,141 | 6.94M |
| 82 | IRON | Disc Medicine, Inc. | 2.55B | 1.46% | 398,824 | - |
| 83 | CLDX | Celldex Therapeutics, Inc. | 2.54B | -1.73% | 404,063 | 1.55M |
| 84 | VERA | Vera Therapeutics, Inc. | 2.52B | -1.15% | 823,695 | - |
| 85 | ELVN | Enliven Therapeutics, Inc. | 2.49B | 1.14% | 539,034 | - |
| 86 | IDYA | IDEAYA Biosciences, Inc. | 2.48B | -3.13% | 896,480 | 218.71M |
| 87 | ADMA | ADMA Biologics, Inc. | 2.44B | 2.63% | 3,543,848 | 510.17M |
| 88 | RARE | Ultragenyx Pharmaceutical Inc. | 2.43B | 0.32% | 1,407,192 | 673.00M |
| 89 | ZLAB | Zai Lab Limited | 2.42B | -0.46% | 244,693 | 460.16M |
| 90 | MLYS | Mineralys Therapeutics, Inc. | 2.41B | 9.79% | 1,910,625 | - |
| 91 | RLAY | Relay Therapeutics, Inc. | 2.41B | -1.85% | 2,914,118 | 15.36M |
| 92 | SRPT | Sarepta Therapeutics, Inc. | 2.26B | 2.92% | 2,428,730 | 2.20B |
| 93 | ADPT | Adaptive Biotechnologies Corporation | 2.20B | 1.21% | 974,011 | 276.98M |
| 94 | DFTX | Definium Therapeutics, Inc. | 2.16B | -0.82% | 1,408,260 | - |
| 95 | AAPG | Ascentage Pharma Group International | 2.10B | 2.03% | 912 | 82.08M |
| 96 | STOK | Stoke Therapeutics, Inc. | 2.06B | 1.10% | 471,752 | 184.42M |
| 97 | MESO | Mesoblast Limited | 2.06B | 0.45% | 147,885 | 65.38M |
| 98 | OCUL | Ocular Therapeutix, Inc. | 2.05B | 0.64% | 2,294,084 | 51.95M |
| 99 | TYRA | Tyra Biosciences, Inc. | 2.02B | -2.04% | 741,033 | - |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.99B | -0.23% | 1,008,920 | 283.06M |
| 101 | ZYME | Zymeworks Inc. | 1.96B | -3.38% | 370,104 | 105.97M |
| 102 | TRVI | Trevi Therapeutics, Inc. | 1.94B | 0.80% | 927,771 | - |
| 103 | PHVS | Pharvaris N.V. | 1.93B | -5.06% | 512,190 | - |
| 104 | ANAB | AnaptysBio, Inc. | 1.92B | 1.57% | 357,945 | 234.60M |
| 105 | INBX | Inhibrx Biosciences, Inc. | 1.88B | -0.33% | 326,794 | 1.30M |
| 106 | GLPG | Galapagos NV | 1.87B | 0.57% | 107,776 | 1.31B |
| 107 | HRMY | Harmony Biosciences Holdings, Inc. | 1.84B | 1.82% | 389,451 | 868.45M |
| 108 | TSHA | Taysha Gene Therapies, Inc. | 1.82B | -0.94% | 1,732,930 | 9.77M |
| 109 | PVLA | Palvella Therapeutics, Inc. | 1.82B | -1.15% | 170,506 | - |
| 110 | VCEL | Vericel Corporation | 1.81B | 2.42% | 342,399 | 276.26M |
| 111 | RXRX | Recursion Pharmaceuticals, Inc. | 1.79B | -2.02% | 12,297,993 | 74.68M |
| 112 | CAPR | Capricor Therapeutics, Inc. | 1.79B | -7.95% | 1,740,109 | 11.13M |
| 113 | SION | Sionna Therapeutics, Inc. | 1.77B | 1.16% | 212,700 | - |
| 114 | NRIX | Nurix Therapeutics, Inc. | 1.74B | 0.66% | 688,925 | 71.78M |
| 115 | INVA | Innoviva, Inc. | 1.71B | 0.52% | 295,027 | 411.33M |
| 116 | ARDX | Ardelyx, Inc. | 1.69B | 8.69% | 11,629,767 | 427.68M |
| 117 | SNDX | Syndax Pharmaceuticals, Inc. | 1.69B | -10.83% | 4,675,638 | 217.17M |
| 118 | GENB | Generate Biomedicines, Inc. | 1.68B | 4.12% | 167,040 | 31.89M |
| 119 | AGIO | Agios Pharmaceuticals, Inc. | 1.67B | 0.57% | 1,165,715 | 66.05M |
| 120 | NBTX | Nanobiotix S.A. | 1.63B | 1.44% | 76,465 | 38.27M |
| 121 | OCS | Oculis Holding AG | 1.63B | - | 161,028 | 1.51M |
| 122 | RAPP | Rapport Therapeutics, Inc. | 1.62B | 2.29% | 222,766 | - |
| 123 | VIR | Vir Biotechnology, Inc. | 1.61B | -2.10% | 1,050,633 | 68.56M |
| 124 | NTLA | Intellia Therapeutics, Inc. | 1.57B | -1.63% | 5,801,000 | 67.67M |
| 125 | NUVB | Nuvation Bio Inc. | 1.56B | 0.90% | 2,643,623 | 62.90M |
| 126 | DMRA | Damora Therapeutics, Inc. | 1.53B | -1.17% | 228,109 | - |
| 127 | ATAI | AtaiBeckley Inc. | 1.52B | -0.48% | 2,355,947 | 4.09M |
| 128 | GLUE | Monte Rosa Therapeutics, Inc. | 1.50B | -1.83% | 653,721 | 123.67M |
| 129 | MAZE | Maze Therapeutics, Inc. | 1.50B | 2.22% | 860,494 | 2.50M |
| 130 | BHVN | Biohaven Ltd. | 1.45B | 0.42% | 1,280,331 | - |
| 131 | IMTX | Immatics N.V. | 1.45B | -1.82% | 210,491 | 56.67M |
| 132 | PGEN | Precigen, Inc. | 1.44B | -1.92% | 1,756,051 | 9.68M |
| 133 | IMCR | Immunocore Holdings plc | 1.43B | 0.90% | 509,839 | 400.02M |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.42B | 0.42% | 297,741 | - |
| 135 | MBX | MBX Biosciences, Inc. | 1.42B | -1.46% | 442,102 | - |
| 136 | WVE | Wave Life Sciences Ltd. | 1.41B | 3.68% | 5,147,251 | 71.80M |
| 137 | IOVA | Iovance Biotherapeutics, Inc. | 1.40B | 1.19% | 9,933,825 | 263.50M |
| 138 | MPLT | MapLight Therapeutics, Inc. | 1.39B | -3.67% | 229,697 | - |
| 139 | VRDN | Viridian Therapeutics, Inc. | 1.38B | -0.45% | 1,461,701 | 70.85M |
| 140 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | -0.04% | 4,602,868 | 73.62M |
| 141 | ABCL | AbCellera Biologics Inc. | 1.34B | 6.75% | 6,462,209 | 75.13M |
| 142 | COAG | Hemab Therapeutics Holdings, Inc. | 1.33B | 88.89% | 4,108,648 | - |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.33B | -3.54% | 380,182 | - |
| 144 | NVAX | Novavax, Inc. | 1.31B | 1.45% | 3,114,228 | 1.12B |
| 145 | CRVS | Corvus Pharmaceuticals, Inc. | 1.30B | 1.78% | 862,006 | - |
| 146 | SVRA | Savara Inc. | 1.30B | -2.29% | 1,132,124 | - |
| 147 | GHRS | GH Research PLC | 1.28B | 0.88% | 126,938 | - |
| 148 | DBVT | DBV Technologies S.A. | 1.26B | -5.38% | 153,634 | 5.64M |
| 149 | OLMA | Olema Pharmaceuticals, Inc. | 1.25B | -0.62% | 792,476 | - |
| 150 | AVLN | Avalyn Pharma Inc. | 1.25B | 1.19% | 829,719 | - |
| 151 | QURE | uniQure N.V. | 1.21B | -4.11% | 1,528,202 | 16.10M |
| 152 | MLTX | MoonLake Immunotherapeutics | 1.20B | 2.14% | 859,555 | - |
| 153 | JBIO | Jade Biosciences, Inc. | 1.20B | -0.70% | 613,225 | - |
| 154 | PHAR | Pharming Group N.V. | 1.19B | 0.74% | 2,008 | 376.13M |
| 155 | ZBIO | Zenas BioPharma, Inc. | 1.15B | 0.21% | 796,926 | 10.00M |
| 156 | FTRE | Fortrea Holdings Inc. | 1.14B | 5.91% | 1,194,646 | 2.72B |
| 157 | URGN | UroGen Pharma Ltd. | 1.12B | -3.48% | 836,015 | 109.79M |
| 158 | EYPT | EyePoint, Inc. | 1.11B | 1.06% | 905,099 | 31.37M |
| 159 | OMER | Omeros Corporation | 1.08B | 3.15% | 1,186,971 | - |
| 160 | XERS | Xeris Biopharma Holdings, Inc. | 1.08B | 2.53% | 1,410,871 | 291.85M |
| 161 | AKTS | Aktis Oncology, Inc. | 1.07B | 3.57% | 258,834 | 6.50M |
| 162 | SEPN | Septerna, Inc. | 1.06B | -0.63% | 201,575 | 45.95M |
| 163 | SPTX | Seaport Therapeutics, Inc. | 1.05B | 10.22% | 4,590,450 | - |
| 164 | IVA | Inventiva S.A. | 1.05B | -3.12% | 207,271 | 7.94M |
| 165 | GERN | Geron Corporation | 1.01B | 2.60% | 9,101,811 | 183.88M |
| 166 | ORIC | ORIC Pharmaceuticals, Inc. | 980.50M | -1.11% | 1,198,580 | - |
| 167 | MRVI | Maravai LifeSciences Holdings, Inc. | 958.86M | 1.36% | 883,067 | 185.74M |
| 168 | PHAT | Phathom Pharmaceuticals, Inc. | 953.96M | 7.23% | 1,708,859 | 204.89M |
| 169 | ANNX | Annexon, Inc. | 934.42M | -2.04% | 1,233,565 | - |
| 170 | XNCR | Xencor, Inc. | 930.67M | 6.37% | 868,260 | 125.58M |
| 171 | CTMX | CytomX Therapeutics, Inc. | 909.96M | -0.95% | 2,490,249 | 76.20M |
| 172 | SLS | SELLAS Life Sciences Group, Inc. | 909.75M | -0.40% | 2,671,837 | - |
| 173 | LBRX | LB Pharmaceuticals Inc | 901.28M | -0.88% | 126,038 | - |
| 174 | SANA | Sana Biotechnology, Inc. | 882.87M | -0.61% | 1,609,714 | - |
| 175 | EVMN | Evommune, Inc. | 882.45M | 2.94% | 333,551 | 13.00M |
| 176 | MNKD | MannKind Corporation | 876.98M | 0.35% | 2,797,388 | 348.97M |
| 177 | ANRO | Alto Neuroscience, Inc. | 874.22M | -2.81% | 208,921 | - |
| 178 | JANX | Janux Therapeutics, Inc. | 872.33M | -0.21% | 485,237 | 10.00M |
| 179 | MGTX | MeiraGTx Holdings plc | 870.96M | 2.06% | 498,521 | 81.39M |
| 180 | TBPH | Theravance Biopharma, Inc. | 864.31M | 0.27% | 298,899 | 107.46M |
| 181 | DRUG | Bright Minds Biosciences Inc. | 861.94M | -1.13% | 379,149 | - |
| 182 | ABUS | Arbutus Biopharma Corporation | 850.78M | 2.86% | 921,987 | 14.08M |
| 183 | SPRY | ARS Pharmaceuticals, Inc. | 849.98M | 3.63% | 1,492,179 | 84.28M |
| 184 | DSGN | Design Therapeutics, Inc. | 830.68M | -2.21% | 498,662 | - |
| 185 | CGEM | Cullinan Therapeutics, Inc. | 812.87M | 2.91% | 522,008 | - |
| 186 | RLMD | Relmada Therapeutics, Inc. | 801.35M | 1.60% | 944,042 | - |
| 187 | SGP | SpyGlass Pharma, Inc. | 799.56M | 4.27% | 83,513 | - |
| 188 | KURA | Kura Oncology, Inc. | 778.45M | -0.68% | 1,217,423 | 67.48M |
| 189 | TRAX | First Tracks Biotherapeutics, Inc. | 777.68M | -3.82% | 595,918 | - |
| 190 | ABSI | Absci Corporation | 764.80M | -1.11% | 2,578,603 | 2.80M |
| 191 | TENX | Tenax Therapeutics, Inc. | 752.46M | -2.52% | 451,689 | - |
| 192 | DRTS | Alpha Tau Medical Ltd. | 751.60M | 2.40% | 915,283 | - |
| 193 | VOR | Vor Biopharma Inc. | 750.47M | -3.35% | 544,904 | - |
| 194 | ALLO | Allogene Therapeutics, Inc. | 739.55M | 0.94% | 4,520,799 | 22.00K |
| 195 | GYRE | Gyre Therapeutics, Inc. | 712.25M | 1.56% | 77,174 | 116.59M |
| 196 | SLDB | Solid Biosciences Inc. | 701.69M | -1.79% | 903,619 | - |
| 197 | LXRX | Lexicon Pharmaceuticals, Inc. | 690.60M | 1.24% | 1,398,155 | 49.80M |
| 198 | FBRX | Forte Biosciences, Inc. | 690.04M | 5.74% | 287,018 | - |
| 199 | ARVN | Arvinas, Inc. | 672.23M | 6.16% | 2,173,382 | 262.60M |
| 200 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 671.48M | -0.24% | 178,625 | - |
| 201 | ANL | Adlai Nortye Ltd. | 620.00M | 8.62% | 593,715 | 5.00M |
| 202 | ACRS | Aclaris Therapeutics, Inc. | 615.92M | 1.61% | 938,141 | 7.83M |
| 203 | CRMD | CorMedix Inc. | 610.95M | 2.64% | 735,949 | 311.71M |
| 204 | OCGN | Ocugen, Inc. | 609.33M | 4.05% | 3,785,126 | 4.41M |
| 205 | PRME | Prime Medicine, Inc. | 604.06M | -3.81% | 1,847,744 | 4.63M |
| 206 | CBIO | Crescent Biopharma, Inc. | 600.45M | -19.22% | 981,732 | 11.88M |
| 207 | ZVRA | Zevra Therapeutics, Inc. | 595.29M | -0.98% | 599,996 | 106.47M |
| 208 | STRO | Sutro Biopharma, Inc. | 589.65M | -2.81% | 199,174 | 102.48M |
| 209 | PROK | ProKidney Corp. | 582.78M | 1.58% | 386,147 | 893.00K |
| 210 | PRTA | Prothena Corporation plc | 572.78M | -3.80% | 515,917 | 9.68M |
| 211 | DNA | Ginkgo Bioworks Holdings, Inc. | 564.61M | 14.66% | 1,970,422 | 170.16M |
| 212 | ALT | Altimmune, Inc. | 547.64M | 8.46% | 4,955,559 | 41.00K |
| 213 | MDXG | MiMedx Group, Inc. | 546.73M | 9.52% | 2,627,640 | 389.42M |
| 214 | AGMB | AgomAb Therapeutics NV | 545.85M | 3.23% | 53,733 | - |
| 215 | TECX | Tectonic Therapeutic, Inc. | 544.99M | 3.77% | 117,253 | - |
| 216 | RIGL | Rigel Pharmaceuticals, Inc. | 543.31M | 1.73% | 196,986 | 294.28M |
| 217 | KYTX | Kyverna Therapeutics, Inc. | 536.90M | 0.80% | 533,171 | - |
| 218 | TRDA | Entrada Therapeutics, Inc. | 529.78M | 7.41% | 323,339 | 25.42M |
| 219 | STTK | Shattuck Labs, Inc. | 528.32M | -2.24% | 391,279 | 1.00M |
| 220 | EIKN | Eikon Therapeutics, Inc. | 524.06M | 0.68% | 158,768 | - |
| 221 | VALN | Valneva SE | 514.39M | -0.56% | 17,187 | 205.07M |
| 222 | VSTM | Verastem, Inc. | 513.00M | 6.96% | 2,040,547 | 30.91M |
| 223 | UPB | Upstream Bio, Inc. | 511.55M | 2.40% | 489,557 | 2.85M |
| 224 | ZURA | Zura Bio Limited | 494.33M | 2.56% | 420,745 | - |
| 225 | XOMA | XOMA Royalty Corporation | 493.07M | 1.07% | 375,529 | 52.15M |
| 226 | IMMX | Immix Biopharma, Inc. | 493.01M | 4.14% | 803,612 | - |
| 227 | CTNM | Contineum Therapeutics, Inc. | 492.84M | 2.96% | 462,102 | - |
| 228 | FULC | Fulcrum Therapeutics, Inc. | 490.42M | 3.23% | 767,198 | 80.00M |
| 229 | EPRX | Eupraxia Pharmaceuticals Inc. | 487.15M | 1.15% | 266,131 | - |
| 230 | ADCT | ADC Therapeutics SA | 487.14M | 1.32% | 979,898 | 81.36M |
| 231 | LYEL | Lyell Immunopharma, Inc. | 485.93M | 5.58% | 54,245 | 36.00K |
| 232 | ENGN | enGene Therapeutics Inc. | 484.00M | -0.62% | 236,028 | - |
| 233 | OVID | Ovid Therapeutics Inc. | 482.77M | 0.72% | 910,598 | 7.25M |
| 234 | CADL | Candel Therapeutics, Inc. | 473.91M | 4.69% | 1,593,970 | - |
| 235 | PRLD | Prelude Therapeutics Incorporated | 472.60M | -10.13% | 1,106,130 | 12.14M |
| 236 | RGNX | REGENXBIO Inc. | 470.75M | 1.67% | 566,206 | 170.44M |
| 237 | SGMT | Sagimet Biosciences Inc. | 469.93M | -5.23% | 1,342,243 | - |
| 238 | FDMT | 4D Molecular Therapeutics, Inc. | 464.06M | 2.48% | 794,026 | 85.21M |
| 239 | PRTC | PureTech Health plc | 460.34M | 5.16% | 45,044 | 4.66M |
| 240 | AURA | Aura Biosciences, Inc. | 450.04M | -0.57% | 205,900 | - |
| 241 | NMRA | Neumora Therapeutics, Inc. | 445.76M | -1.21% | 3,502,540 | - |
| 242 | AVIR | Atea Pharmaceuticals, Inc. | 444.57M | 1.27% | 199,130 | - |
| 243 | ASMB | Assembly Biosciences, Inc. | 437.05M | 2.04% | 70,771 | 72.30M |
| 244 | IVVD | Invivyd, Inc. | 429.86M | 8.57% | 1,592,263 | 53.43M |
| 245 | LXEO | Lexeo Therapeutics, Inc. | 427.48M | 1.32% | 448,679 | - |
| 246 | CLYM | Climb Bio, Inc. | 425.62M | 0.34% | 1,790,925 | - |
| 247 | VNDA | Vanda Pharmaceuticals Inc. | 420.95M | -1.41% | 648,208 | 216.11M |
| 248 | NGNE | Neurogene Inc. | 419.28M | 2.91% | 131,677 | 925.00K |
| 249 | ENTA | Enanta Pharmaceuticals, Inc. | 416.43M | 3.31% | 158,705 | 66.98M |
| 250 | IPSC | Century Therapeutics, Inc. | 415.93M | 0.87% | 444,070 | 109.16M |
| 251 | BNTC | Benitec Biopharma Inc. | 409.35M | -0.83% | 74,412 | - |
| 252 | LRMR | Larimar Therapeutics, Inc. | 409.30M | -2.96% | 2,193,107 | - |
| 253 | VTVT | vTv Therapeutics Inc. | 393.20M | -1.72% | 32,546 | 17.00K |
| 254 | AUTL | Autolus Therapeutics plc | 391.23M | 4.26% | 857,314 | 75.39M |
| 255 | NAGE | Niagen Bioscience, Inc. | 389.20M | 2.54% | 425,868 | 129.42M |
| 256 | RCKT | Rocket Pharmaceuticals, Inc. | 388.48M | 2.30% | 1,826,990 | - |
| 257 | SRZN | Surrozen, Inc. | 385.95M | 0.60% | 62,057 | 3.48M |
| 258 | LCTX | Lineage Cell Therapeutics, Inc. | 381.10M | 1.32% | 1,362,840 | 14.56M |
| 259 | PBYI | Puma Biotechnology, Inc. | 381.06M | -0.27% | 167,962 | 228.37M |
| 260 | XFOR | X4 Pharmaceuticals, Inc. | 380.95M | 2.95% | 246,343 | 35.11M |
| 261 | IRD | Opus Genetics, Inc. | 367.01M | 0.59% | 676,603 | 14.20M |
| 262 | AVTX | Avalo Therapeutics, Inc. | 366.25M | 2.31% | 722,384 | 59.00K |
| 263 | MNPR | Monopar Therapeutics Inc. | 356.36M | 2.11% | 79,105 | - |
| 264 | CMPX | Compass Therapeutics, Inc. | 352.97M | 10.73% | 10,661,874 | 850.00K |
| 265 | IMRX | Immuneering Corporation | 347.42M | 2.48% | 647,433 | - |
| 266 | RZLT | Rezolute, Inc. | 342.78M | 3.12% | 1,474,938 | - |
| 267 | NAUT | Nautilus Biotechnology, Inc. | 341.72M | 2.66% | 266,709 | - |
| 268 | YDES | YD Bio Limited | 337.54M | -5.88% | 3,806 | 510.36K |
| 269 | SLN | Silence Therapeutics plc | 336.78M | -2.46% | 96,081 | 559.00K |
| 270 | BCYC | Bicycle Therapeutics plc | 334.59M | 1.69% | 398,186 | 63.50M |
| 271 | PALI | Palisade Bio, Inc. | 333.17M | -0.50% | 2,801,246 | - |
| 272 | DMAC | DiaMedica Therapeutics Inc. | 332.99M | 2.15% | 192,535 | - |
| 273 | GLSI | Greenwich LifeSciences, Inc. | 328.35M | 0.34% | 115,527 | - |
| 274 | CABA | Cabaletta Bio, Inc. | 327.29M | -1.67% | 915,843 | - |
| 275 | ARMP | Armata Pharmaceuticals, Inc. | 325.67M | -10.92% | 56,700 | 4.90M |
| 276 | IKT | Inhibikase Therapeutics, Inc. | 325.56M | 1.06% | 945,959 | 1.00 |
| 277 | ABEO | Abeona Therapeutics Inc. | 308.87M | -0.55% | 769,084 | 5.82M |
| 278 | AVXL | Anavex Life Sciences Corp. | 307.67M | -0.60% | 504,879 | - |
| 279 | NGEN | NervGen Pharma Corp. | 305.92M | 4.13% | 82,151 | - |
| 280 | ACIU | AC Immune SA | 295.62M | -1.65% | 457,980 | 4.62M |
| 281 | ZNTL | Zentalis Pharmaceuticals, Inc. | 290.11M | 2.00% | 731,650 | 26.87M |
| 282 | TARA | Protara Therapeutics, Inc. | 287.73M | -0.19% | 395,428 | - |
| 283 | CCCC | C4 Therapeutics, Inc. | 284.93M | 3.18% | 4,780,376 | 35.95M |
| 284 | EDIT | Editas Medicine, Inc. | 283.83M | -3.33% | 858,477 | 40.52M |
| 285 | CLLS | Cellectis S.A. | 283.24M | 1.79% | 9,944 | 79.59M |
| 286 | ELDN | Eledon Pharmaceuticals, Inc. | 280.32M | 1.37% | 1,215,014 | - |
| 287 | FHTX | Foghorn Therapeutics Inc. | 279.41M | 0.21% | 71,924 | 30.91M |
| 288 | LENZ | LENZ Therapeutics, Inc. | 278.43M | -1.11% | 852,212 | 19.09M |
| 289 | CHRS | Coherus Oncology, Inc. | 277.59M | 1.41% | 560,647 | 42.17M |
| 290 | NBP | NovaBridge Biosciences | 275.24M | -3.64% | 1,857,842 | - |
| 291 | ARTV | Artiva Biotherapeutics, Inc. | 266.94M | 5.47% | 193,775 | 251.00K |
| 292 | NERV | Minerva Neurosciences, Inc. | 266.12M | -6.18% | 108,381 | - |
| 293 | ALEC | Alector, Inc. | 260.46M | -0.42% | 420,253 | 21.05M |
| 294 | HELP | Cybin Inc. | 257.68M | -3.01% | 705,610 | - |
| 295 | CGEN | Compugen Ltd. | 256.24M | 1.88% | 418,455 | 72.76M |
| 296 | ADAG | Adagene Inc. | 252.40M | 3.80% | 150,137 | 7.67M |
| 297 | SLGL | Sol-Gel Technologies Ltd. | 247.17M | 2.12% | 10,894 | 19.39M |
| 298 | ARCT | Arcturus Therapeutics Holdings Inc. | 245.29M | 0.12% | 311,692 | 82.03M |
| 299 | SABS | SAB Biotherapeutics, Inc. | 243.86M | -7.22% | 628,632 | 114.70K |
| 300 | CDXS | Codexis, Inc. | 242.62M | -5.32% | 771,232 | 70.39M |
| 301 | HRTX | Heron Therapeutics, Inc. | 239.57M | 5.83% | 2,705,757 | 154.90M |
| 302 | ACHV | Achieve Life Sciences, Inc. | 233.19M | -0.23% | 467,716 | - |
| 303 | OBIO | Orchestra BioMed Holdings, Inc. | 232.33M | -0.50% | 158,418 | 33.48M |
| 304 | PLYX | Polaryx Therapeutics, Inc. | 231.04M | -7.05% | 88,266 | - |
| 305 | MIST | Milestone Pharmaceuticals Inc. | 229.35M | 3.89% | 646,269 | 1.55M |
| 306 | ALXO | ALX Oncology Holdings Inc. | 227.41M | -0.59% | 1,241,027 | - |
| 307 | KROS | Keros Therapeutics, Inc. | 227.36M | 3.33% | 268,343 | 244.06M |
| 308 | NVCT | Nuvectis Pharma, Inc. | 226.24M | -0.23% | 29,052 | - |
| 309 | FENC | Fennec Pharmaceuticals Inc. | 224.95M | 0.54% | 145,467 | 44.64M |
| 310 | VYGR | Voyager Therapeutics, Inc. | 224.09M | 0.80% | 338,987 | 40.37M |
| 311 | MDWD | MediWound Ltd. | 213.73M | 0.79% | 26,844 | 16.96M |
| 312 | CAMP | Camp4 Therapeutics Corporation | 210.30M | -2.88% | 104,292 | 3.50M |
| 313 | NKTX | Nkarta, Inc. | 208.88M | 5.78% | 1,034,196 | - |
| 314 | CNTX | Context Therapeutics Inc. | 208.57M | -3.81% | 874,766 | - |
| 315 | RNA | Atrium Therapeutics, Inc. | 208.37M | 5.17% | 169,380 | 18.62M |
| 316 | REPL | Replimune Group, Inc. | 206.43M | -2.72% | 3,149,005 | - |
| 317 | OABI | OmniAb, Inc. | 202.70M | 0.72% | 510,583 | 18.67M |
| 318 | MGNX | MacroGenics, Inc. | 198.94M | 1.62% | 447,201 | 149.50M |
| 319 | ELTX | Elicio Therapeutics, Inc. | 197.76M | 1.22% | 92,723 | - |
| 320 | KPTI | Karyopharm Therapeutics Inc. | 197.70M | 5.54% | 229,771 | 146.07M |
| 321 | KRRO | Korro Bio, Inc. | 195.71M | 0.59% | 74,951 | 6.39M |
| 322 | ENLV | Enlivex Ltd. | 193.70M | -0.46% | 284,838 | - |
| 323 | UNCY | Unicycive Therapeutics, Inc. | 193.57M | 0.13% | 483,249 | - |
| 324 | TNXP | Tonix Pharmaceuticals Holding Corp. | 193.19M | 5.18% | 328,612 | 13.11M |
| 325 | OKUR | OnKure Therapeutics, Inc. | 191.07M | -10.25% | 187,529 | - |
| 326 | HUMA | Humacyte, Inc. | 189.89M | 1.60% | 2,029,185 | 2.04M |
| 327 | WHWK | Whitehawk Therapeutics, Inc. | 188.31M | -0.50% | 259,889 | 7.15M |
| 328 | DTIL | Precision BioSciences, Inc. | 187.85M | 1.82% | 237,315 | 34.26M |
| 329 | CRBU | Caribou Biosciences, Inc. | 184.54M | -0.53% | 1,136,714 | 11.16M |
| 330 | CNTN | Canton Strategic Holdings, Inc. | 183.00M | - | 336,769 | - |
| 331 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 182.69M | 4.25% | 536,825 | - |
| 332 | FATE | Fate Therapeutics, Inc. | 177.88M | 22.40% | 5,126,383 | 6.65M |
| 333 | MENS | Jyong Biotech Ltd. | 173.03M | -0.88% | 51,785 | - |
| 334 | ABOS | Acumen Pharmaceuticals, Inc. | 171.90M | -0.42% | 174,786 | - |
| 335 | TLSA | Tiziana Life Sciences Ltd | 171.02M | 4.69% | 77,427 | - |
| 336 | PLX | Protalix BioTherapeutics, Inc. | 170.81M | -1.40% | 669,606 | 52.74M |
| 337 | ANTX | AN2 Therapeutics, Inc. | 168.46M | 2.86% | 105,460 | - |
| 338 | RNAC | Cartesian Therapeutics, Inc. | 164.36M | -0.32% | 205,007 | 1.78M |
| 339 | PRQR | ProQR Therapeutics N.V. | 163.31M | -1.27% | 462,932 | 19.19M |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 160.98M | 2.58% | 107,981 | 2.00M |
| 341 | EDSA | Edesa Biotech, Inc. | 156.30M | -3.75% | 720,814 | - |
| 342 | SPRB | Spruce Biosciences, Inc. | 154.79M | -0.07% | 30,427 | 697.00K |
| 343 | MOLN | Molecular Partners AG | 153.58M | 0.24% | 1,982 | 856.30K |
| 344 | TNYA | Tenaya Therapeutics, Inc. | 153.16M | 2.13% | 2,443,860 | - |
| 345 | KZIA | Kazia Therapeutics Limited | 153.01M | -1.83% | 246,064 | 1.27M |
| 346 | IFRX | InflaRx N.V. | 151.82M | 1.45% | 1,108,957 | 34.44K |
| 347 | ALPS | Alps Group Inc | 151.41M | 1.10% | 7,061 | 3.74M |
| 348 | GALT | Galectin Therapeutics Inc. | 149.43M | - | 178,586 | - |
| 349 | BDTX | Black Diamond Therapeutics, Inc. | 148.95M | -1.89% | 757,951 | 70.00M |
| 350 | HURA | TuHURA Biosciences, Inc. | 148.14M | 4.02% | 459,674 | - |
| 351 | AGEN | Agenus Inc. | 147.45M | -1.79% | 518,841 | 114.20M |
| 352 | SPRO | Spero Therapeutics, Inc. | 143.57M | -1.20% | 494,431 | 66.80M |
| 353 | CNTB | Connect Biopharma Holdings Limited | 139.61M | - | 37,663 | 64.00K |
| 354 | IPHA | Innate Pharma S.A. | 132.09M | - | 10,333 | 10.57M |
| 355 | EQ | Equillium, Inc. | 131.51M | 1.96% | 145,925 | 4.39M |
| 356 | IMUX | Immunic, Inc. | 131.24M | 0.31% | 184,973 | - |
| 357 | ACOG | Alpha Cognition Inc. | 131.08M | 0.84% | 17,503 | 10.22M |
| 358 | KLRS | Kalaris Therapeutics, Inc. | 125.19M | -1.09% | 86,116 | - |
| 359 | GNLX | Genelux Corporation | 122.02M | 3.00% | 118,043 | 8.00K |
| 360 | PEPG | PepGen Inc. | 120.95M | 6.71% | 1,872,329 | - |
| 361 | AARD | Aardvark Therapeutics, Inc. | 119.12M | 0.55% | 82,385 | - |
| 362 | CRDF | Cardiff Oncology, Inc. | 116.91M | -1.16% | 392,145 | 593.00K |
| 363 | VANI | Vivani Medical, Inc. | 115.12M | 1.49% | 70,752 | - |
| 364 | SEER | Seer, Inc. | 114.53M | 4.10% | 754,392 | 16.58M |
| 365 | CGTX | Cognition Therapeutics, Inc. | 114.37M | 1.59% | 832,754 | - |
| 366 | TTRX | Turn Therapeutics Inc. | 113.19M | 2.97% | 18,444 | - |
| 367 | GUTS | Fractyl Health, Inc. | 110.94M | 9.69% | 2,612,539 | 3.00K |
| 368 | CBUS | Cibus, Inc. | 110.61M | 3.57% | 324,603 | 3.64M |
| 369 | PYXS | Pyxis Oncology, Inc. | 108.07M | 1.18% | 102,323 | 13.86M |
| 370 | VRCA | Verrica Pharmaceuticals Inc. | 107.71M | -1.57% | 25,399 | 35.58M |
| 371 | ANIX | Anixa Biosciences, Inc. | 105.28M | 4.67% | 159,713 | - |
| 372 | NRXP | NRx Pharmaceuticals, Inc. | 102.08M | 3.69% | 484,070 | 1.23M |
| 373 | KALA | KALA BIO, Inc. | 101.31M | 3.71% | 3,418,347 | - |
| 374 | NTHI | NeOnc Technologies Holdings, Inc. | 101.14M | -8.14% | 60,257 | 39.99K |
| 375 | ONCY | Oncolytics Biotech Inc. | 101.04M | -1.13% | 647,725 | - |
| 376 | BMEA | Biomea Fusion, Inc. | 99.05M | 0.74% | 1,309,418 | - |
| 377 | CUE | Cue Biopharma, Inc. | 99.03M | 106.38% | 18,920,171 | 27.47M |
| 378 | PMN | ProMIS Neurosciences, Inc. | 98.73M | -0.27% | 33,516 | - |
| 379 | COYA | Coya Therapeutics, Inc. | 97.82M | -1.42% | 120,749 | 7.95M |
| 380 | ALDX | Aldeyra Therapeutics, Inc. | 95.69M | 4.61% | 751,391 | - |
| 381 | RANI | Rani Therapeutics Holdings, Inc. | 93.82M | 5.87% | 620,256 | 1.63M |
| 382 | NRXS | NeurAxis, Inc. | 92.96M | 8.46% | 293,069 | 3.57M |
| 383 | INO | Inovio Pharmaceuticals, Inc. | 90.13M | -1.79% | 1,076,887 | 65.34K |
| 384 | ACET | Adicet Bio, Inc. | 88.14M | 8.61% | 119,244 | - |
| 385 | OKYO | OKYO Pharma Limited | 87.64M | 7.05% | 89,678 | - |
| 386 | GOSS | Gossamer Bio, Inc. | 86.79M | 0.54% | 2,371,539 | 48.47M |
| 387 | PYPD | PolyPid Ltd. | 84.73M | -1.33% | 13,370 | - |
| 388 | PTHS | Pelthos Therapeutics Inc. | 83.89M | - | 17,703 | 16.80M |
| 389 | CSBR | Champions Oncology, Inc. | 83.18M | 0.50% | 6,627 | 57.95M |
| 390 | LONA | LeonaBio, Inc. | 82.85M | -3.08% | 31,016 | - |
| 391 | EXOZ | eXoZymes, Inc. | 82.67M | -2.30% | 10,978 | -700.00 |
| 392 | ATHE | Alterity Therapeutics Limited | 82.47M | 4.07% | 39,595 | 4.43M |
| 393 | ATYR | aTyr Pharma, Inc. | 81.73M | 3.23% | 1,568,953 | 190.00K |
| 394 | MAIA | MAIA Biotechnology, Inc. | 81.30M | 0.75% | 577,441 | - |
| 395 | ACRV | Acrivon Therapeutics, Inc. | 80.98M | 12.97% | 867,347 | - |
| 396 | GANX | Gain Therapeutics, Inc. | 79.41M | -0.53% | 415,464 | - |
| 397 | ICCC | ImmuCell Corporation | 78.98M | 3.19% | 16,482 | 27.64M |
| 398 | XBIT | XBiotech Inc. | 77.74M | -0.78% | 9,855 | - |
| 399 | FBIO | Fortress Biotech, Inc. | 75.03M | 1.30% | 242,978 | 63.26M |
| 400 | PLRX | Pliant Therapeutics, Inc. | 74.30M | -1.64% | 382,507 | - |
| 401 | PMVP | PMV Pharmaceuticals, Inc. | 74.13M | - | 177,303 | - |
| 402 | QTTB | Q32 Bio Inc. | 73.73M | -10.00% | 300,466 | 53.74M |
| 403 | TCRX | TScan Therapeutics, Inc. | 73.32M | 5.17% | 617,067 | 10.33M |
| 404 | MCRB | Seres Therapeutics, Inc. | 72.95M | 3.26% | 23,074 | 789.00K |
| 405 | FLNA | Filana Therapeutics, Inc. | 72.94M | 4.14% | 816,377 | - |
| 406 | ACTU | Actuate Therapeutics, Inc. | 71.14M | 2.04% | 93,665 | - |
| 407 | IBO | Impact BioMedical Inc. | 70.84M | -3.38% | 62,891 | 32.00K |
| 408 | ANVS | Annovis Bio, Inc. | 69.06M | 1.52% | 708,087 | - |
| 409 | MNOV | MediciNova, Inc. | 68.91M | 0.72% | 15,650 | 409.66K |
| 410 | ESLA | Estrella Immunopharma, Inc. | 68.26M | -2.44% | 121,820 | - |
| 411 | OSTX | OS Therapies Incorporated | 67.68M | -5.29% | 555,668 | - |
| 412 | IMMP | Immutep Limited | 64.92M | -5.65% | 1,606,704 | 5.28M |
| 413 | IMA | ImageneBio, Inc. | 63.31M | -5.98% | 109,887 | 800.00K |
| 414 | CING | Cingulate Inc. | 62.45M | 4.27% | 316,809 | - |
| 415 | BYSI | BeyondSpring Inc. | 61.27M | -1.99% | 9,865 | 1.88M |
| 416 | HYFT | MindWalk Holdings Corp. | 60.10M | 1.68% | 100,451 | 20.70M |
| 417 | INKT | MiNK Therapeutics, Inc. | 57.65M | -4.84% | 19,744 | - |
| 418 | IBIO | iBio, Inc. | 57.47M | -5.92% | 693,423 | 300.00K |
| 419 | SGMO | Sangamo Therapeutics, Inc. | 55.93M | 13.26% | 17,421,394 | 39.55M |
| 420 | TIL | Instil Bio, Inc. | 54.76M | 1.19% | 7,371 | - |
| 421 | PDSB | PDS Biotechnology Corporation | 54.74M | 0.79% | 284,810 | - |
| 422 | KZR | Kezar Life Sciences, Inc. | 54.15M | 0.27% | 57,308 | - |
| 423 | MGX | Metagenomi Therapeutics, Inc. | 52.29M | 0.72% | 125,905 | 25.21M |
| 424 | ENTX | Entera Bio Ltd. | 51.28M | -7.56% | 282,118 | 42.00K |
| 425 | RLYB | Rallybio Corporation | 49.78M | 4.79% | 70,466 | 858.00K |
| 426 | DWTX | Dogwood Therapeutics, Inc. | 48.77M | 2.10% | 48,887 | - |
| 427 | RADX | Radiopharm Theranostics Limited | 48.63M | 3.28% | 32,933 | 10.86M |
| 428 | TELO | Telomir Pharmaceuticals, Inc. | 48.13M | - | 156,790 | - |
| 429 | XLO | Xilio Therapeutics, Inc. | 48.11M | 5.05% | 49,475 | 43.77M |
| 430 | HYPD | Hyperion DeFi, Inc. | 47.62M | 3.59% | 186,001 | 813.46K |
| 431 | NTRB | Nutriband Inc. | 46.92M | -0.13% | 3,997 | 2.04M |
| 432 | ATOS | Atossa Therapeutics, Inc. | 45.90M | -0.74% | 35,695 | - |
| 433 | PSTV | Plus Therapeutics, Inc. | 41.79M | -0.81% | 85,285 | 5.21M |
| 434 | MREO | Mereo BioPharma Group plc | 41.50M | -3.13% | 1,694,416 | 500.00K |
| 435 | LITS | Lite Strategy, Inc. | 41.09M | -1.74% | 186,093 | - |
| 436 | INMB | INmune Bio Inc. | 40.14M | 5.59% | 187,106 | 50.00K |
| 437 | ATRA | Atara Biotherapeutics, Inc. | 40.07M | 2.73% | 36,987 | 120.77M |
| 438 | RNXT | RenovoRx, Inc. | 39.80M | 3.92% | 386,576 | 1.12M |
| 439 | LIXT | Lixte Biotechnology Holdings, Inc. | 39.38M | -3.14% | 7,325 | - |
| 440 | PTN | Palatin Technologies, Inc. | 38.81M | 0.10% | 24,763 | 8.96M |
| 441 | ALGS | Aligos Therapeutics, Inc. | 37.68M | 1.67% | 203,230 | 2.19M |
| 442 | EVAX | Evaxion A/S | 37.49M | 1.93% | 29,998 | 7.53M |
| 443 | VERU | Veru Inc. | 36.27M | 0.44% | 51,554 | 16.89M |
| 444 | GRCE | Grace Therapeutics, Inc. | 36.21M | 4.46% | 802,138 | - |
| 445 | SNSE | Sensei Biotherapeutics, Inc. | 36.13M | 1.28% | 28,473 | - |
| 446 | APLM | Apollomics, Inc. | 35.62M | 24.77% | 5,276 | 8.84M |
| 447 | ATNM | Actinium Pharmaceuticals, Inc. | 35.23M | 1.80% | 144,980 | 90.00K |
| 448 | BOLD | Boundless Bio, Inc. | 35.18M | 7.53% | 70,345 | - |
| 449 | HOWL | Werewolf Therapeutics, Inc. | 35.14M | 0.47% | 125,153 | 1.14M |
| 450 | CRVO | CervoMed Inc. | 34.35M | 0.54% | 59,564 | 4.01M |
| 451 | DARE | Daré Bioscience, Inc. | 34.07M | 2.63% | 352,263 | 1.03M |
| 452 | PLUR | Pluri Inc. | 33.67M | -3.76% | 772 | 1.34M |
| 453 | NXTC | NextCure, Inc. | 33.33M | 1.63% | 90,082 | - |
| 454 | IGC | IGC Pharma, Inc. | 33.09M | 4.79% | 1,129,088 | 1.11M |
| 455 | QNTM | Quantum BioPharma Ltd. | 32.56M | -3.14% | 360,008 | - |
| 456 | SNTI | Senti Biosciences Holdings, Inc. | 31.77M | 10.28% | 256,687 | 22.00K |
| 457 | NRSN | NeuroSense Therapeutics Ltd. | 31.69M | 9.21% | 186,096 | - |
| 458 | BCTX | BriaCell Therapeutics Corp. | 30.36M | - | 102,484 | - |
| 459 | PLRZ | Polyrizon Ltd. | 29.95M | 0.63% | 51,776 | - |
| 460 | TVRD | Tvardi Therapeutics, Inc. | 29.46M | -0.32% | 24,850 | - |
| 461 | TPST | Tempest Therapeutics, Inc. | 29.26M | 2.51% | 154,179 | - |
| 462 | SKYE | Skye Bioscience, Inc. | 28.93M | -6.29% | 318,269 | - |
| 463 | RNTX | Rein Therapeutics Inc. | 28.88M | -23.99% | 10,369,589 | - |
| 464 | DYAI | Dyadic International, Inc. | 28.79M | 0.70% | 17,919 | 3.09M |
| 465 | KYNB | Kyntra Bio, Inc. | 28.69M | -2.48% | 4,747 | 6.44M |
| 466 | LSTA | Lisata Therapeutics, Inc. | 28.27M | 0.32% | 7,971 | 170.00K |
| 467 | NEUP | Neuphoria Therapeutics Inc. | 28.19M | -0.76% | 17,981 | 14.99M |
| 468 | NNVC | NanoViricides, Inc. | 28.07M | 4.84% | 296,182 | - |
| 469 | TVGN | Tevogen Bio Holdings Inc. | 27.73M | 0.30% | 7,249 | - |
| 470 | CELU | Celularity Inc. | 27.60M | 2.43% | 1,580,691 | 40.58M |
| 471 | OTLK | Outlook Therapeutics, Inc. | 27.43M | 4.88% | 3,748,314 | 205.70K |
| 472 | JSPR | Jasper Therapeutics, Inc. | 26.05M | -0.61% | 222,675 | - |
| 473 | BRNS | Barinthus Biotherapeutics plc | 25.73M | -3.08% | 5,463 | 14.97M |
| 474 | ABVC | ABVC BioPharma, Inc. | 25.45M | - | 16,745 | 797.92K |
| 475 | LGVN | Longeveron Inc. | 24.92M | 0.07% | 206,799 | 1.20M |
| 476 | VTGN | Vistagen Therapeutics, Inc. | 24.79M | 2.02% | 427,435 | 789.00K |
| 477 | MRKR | Marker Therapeutics, Inc. | 24.51M | 0.68% | 34,510 | 3.55M |
| 478 | LTRN | Lantern Pharma Inc. | 23.76M | 3.41% | 259,240 | - |
| 479 | CRIS | Curis, Inc. | 23.67M | -1.33% | 108,265 | 9.44M |
| 480 | AEON | AEON Biopharma, Inc. | 22.52M | -3.58% | 73,988 | - |
| 481 | SER | Serina Therapeutics, Inc. | 22.37M | -0.16% | 23,263 | 130.00K |
| 482 | QNCX | Quince Therapeutics, Inc. | 21.68M | 1.53% | 743,555 | - |
| 483 | VYNE | VYNE Therapeutics Inc. | 21.37M | 0.71% | 104,045 | 570.00K |
| 484 | OSRH | OSR Holdings, Inc. | 21.09M | -9.43% | 13,469,881 | 2.91M |
| 485 | KTTA | Pasithea Therapeutics Corp. | 20.97M | 21.06% | 1,682,097 | - |
| 486 | XCUR | Exicure, Inc. | 20.65M | -3.57% | 12,567 | 500.00K |
| 487 | ALLR | Allarity Therapeutics, Inc. | 20.56M | -3.70% | 159,834 | 320.00K |
| 488 | CVKD | Cadrenal Therapeutics, Inc. | 19.55M | -4.80% | 128,108 | - |
| 489 | COCP | Cocrystal Pharma, Inc. | 19.02M | -3.50% | 145,023 | - |
| 490 | LPCN | Lipocine Inc. | 18.70M | - | 87,475 | 1.98M |
| 491 | CVM | CEL-SCI Corporation | 18.45M | -25.73% | 769,603 | - |
| 492 | TOVX | Theriva Biologics, Inc. | 17.88M | 8.64% | 3,794,472 | - |
| 493 | LEXX | Lexaria Bioscience Corp. | 17.63M | 7.94% | 106,118 | 368.00K |
| 494 | NCEL | NewcelX Ltd. | 17.55M | -12.70% | 35,408 | - |
| 495 | ICU | SeaStar Medical Holding Corporation | 17.45M | 5.56% | 111,636 | 1.23M |
| 496 | GNTA | Genenta Science S.p.A. | 17.22M | 2.64% | 21,535 | - |
| 497 | PASG | Passage Bio, Inc. | 15.94M | -2.74% | 25,200 | - |
| 498 | CTXR | Citius Pharmaceuticals, Inc. | 15.66M | 0.57% | 864,133 | 3.94M |
| 499 | TRAW | Traws Pharma, Inc. | 15.13M | 4.20% | 206,952 | 2.79M |
| 500 | INAB | IN8bio, Inc. | 14.77M | 2.04% | 22,336 | - |